Gad Alon1, Keith McBride. 1. Department of Physical Therapy, University of Maryland, School of Medicine, Baltimore, MD 21201-1082, USA. galon@som.umaryland.edu
Abstract
OBJECTIVE: To test the efficacy and safety of the NESS Handmaster neuroprosthesis with subjects with C5 or C6 tetraplegia. DESIGN: Interventional, nonrandomized case series. SETTING: Subjects' residence and university research laboratory. PARTICIPANTS: Men, 3 to 17 years after C5 (n=5) and C6 (n=2) spinal cord injury (SCI). INTERVENTION: Subjects practiced with the neuroprosthesis daily to regain grasp, hold, and release ability and to restore selected functions of 1 of the 2 paralyzed hands. Subjects were observed 2 to 3 times weekly for 3 weeks. MAIN OUTCOME MEASURES: Three activities of daily living (ADL) tasks: (1) pick up a telephone, (2) eat food with a fork, and (3) perform 1 individually selected ADL task and 2 grasp, hold, and release tasks (lift a videocassette, lift a 150-g weight). Secondary outcomes were grip strength, electrically induced finger motion, and Fugl-Meyer spherical grasp. Nonparametric data were analyzed with the Wilcoxon signed-rank test, and parametric data (grip strength and finger motion) were analyzed by analysis of variance. All tests were considered significant at P equal to.01. RESULTS: At study completion, all 7 subjects were 100% successful at using the Handmaster in the studied ADL and grasp, hold, and release tasks. Significant improvements occurred in grip strength (from.57+/-.98N at baseline to 16.5+/-4.4N), finger linear motion (from 0.0cm at baseline to 8.4+/-3.2cm), and Fugl-Meyer scores. No safety issues were encountered. Six of 7 subjects rated their overall performance as "excellent." CONCLUSIONS: The Handmaster is a safe, noninvasive neuroprosthesis that improves hand function of selected subjects with C5 or C6 SCI. Copyright 2003 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation
OBJECTIVE: To test the efficacy and safety of the NESS Handmaster neuroprosthesis with subjects with C5 or C6 tetraplegia. DESIGN: Interventional, nonrandomized case series. SETTING: Subjects' residence and university research laboratory. PARTICIPANTS: Men, 3 to 17 years after C5 (n=5) and C6 (n=2) spinal cord injury (SCI). INTERVENTION: Subjects practiced with the neuroprosthesis daily to regain grasp, hold, and release ability and to restore selected functions of 1 of the 2 paralyzed hands. Subjects were observed 2 to 3 times weekly for 3 weeks. MAIN OUTCOME MEASURES: Three activities of daily living (ADL) tasks: (1) pick up a telephone, (2) eat food with a fork, and (3) perform 1 individually selected ADL task and 2 grasp, hold, and release tasks (lift a videocassette, lift a 150-g weight). Secondary outcomes were grip strength, electrically induced finger motion, and Fugl-Meyer spherical grasp. Nonparametric data were analyzed with the Wilcoxon signed-rank test, and parametric data (grip strength and finger motion) were analyzed by analysis of variance. All tests were considered significant at P equal to.01. RESULTS: At study completion, all 7 subjects were 100% successful at using the Handmaster in the studied ADL and grasp, hold, and release tasks. Significant improvements occurred in grip strength (from.57+/-.98N at baseline to 16.5+/-4.4N), finger linear motion (from 0.0cm at baseline to 8.4+/-3.2cm), and Fugl-Meyer scores. No safety issues were encountered. Six of 7 subjects rated their overall performance as "excellent." CONCLUSIONS: The Handmaster is a safe, noninvasive neuroprosthesis that improves hand function of selected subjects with C5 or C6 SCI. Copyright 2003 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation
Authors: Douglas J Weber; Elizabeth R Skidmore; Christian Niyonkuru; Chia-Lin Chang; Lynne M Huber; Michael C Munin Journal: Arch Phys Med Rehabil Date: 2010-05 Impact factor: 3.966
Authors: Ashraf S Gorgey; Mark K Timmons; David R Dolbow; Justin Bengel; Kendall C Fugate-Laus; Lori A Michener; David R Gater Journal: Eur J Appl Physiol Date: 2016-05-07 Impact factor: 3.078
Authors: N A Brill; S N Naufel; K Polasek; C Ethier; J Cheesborough; S Agnew; L E Miller; D J Tyler Journal: J Neural Eng Date: 2017-08-21 Impact factor: 5.379